BRIEF published on 02/13/2025 at 08:05, 1 month 11 days ago KPS AG publie ses résultats financiers du premier trimestre 2024/2025 Résultats Trimestriels Baisse Des Revenus Marché De Détail KPS SA Amélioration De L'EBITDA
BRIEF published on 02/13/2025 at 08:05, 1 month 11 days ago KPS AG Reports First Quarter 2024/2025 Financial Results Revenue Decline KPS AG Quarterly Results EBITDA Improvement Retail Market
PRESS RELEASE published on 02/13/2025 at 08:00, 1 month 11 days ago KPS on track in the first quarter of 2024/2025 KPS AG announces positive first quarter results for 2024/2025 financial year with revenue of €32.5 million and EBITDA of €2.2 million EBITDA Revenue KPS AG First Quarter Results 2024/2025
BRIEF published on 02/11/2025 at 18:35, 1 month 12 days ago KPS AG passe de Prime à General Standard à la Bourse de Francfort Bourse KPS SA Francfort Norme Prime Norme Générale
BRIEF published on 02/11/2025 at 18:35, 1 month 12 days ago KPS AG to Transition from Prime to General Standard on Frankfurt Stock Exchange Stock Exchange KPS AG Frankfurt Prime Standard General Standard
PRESS RELEASE published on 02/11/2025 at 18:30, 1 month 12 days ago EQS-Adhoc: KPS AG decides to apply for a change from the Prime Standard to the General Standard of the Frankfurt Stock Exchange KPS AG applies for a change from the Prime Standard to the General Standard of the Frankfurt Stock Exchange, aiming to reduce listing expenses Frankfurt Stock Exchange KPS AG Prime Standard General Standard Listing Expenses
BRIEF published on 01/31/2025 at 12:25, 1 month 24 days ago KPS AG fait face aux défis du marché mais élargit sa clientèle en 2023/2024 Résultats Financiers Défis Du Marché KPS SA Clientèle Secteur De La Vente Au Détail
BRIEF published on 01/31/2025 at 12:25, 1 month 24 days ago KPS AG Faces Market Challenges but Expands Customer Base in 2023/2024 Financial Results Market Challenges KPS AG Retail Sector Customer Base
PRESS RELEASE published on 01/31/2025 at 12:20, 1 month 24 days ago KPS meets the 2023/2024 forecast and maintains its position with an expanded customer base in a challenging market environment KPS AG meets 2023/2024 forecast with €145.4m revenue in challenging market, expands customer base by 25%, adjusts strategies for retail sector resilience Revenue KPS AG Retail Sector Customer Base 2023/2024 Forecast
BRIEF published on 07/25/2024 at 08:05, 7 months 30 days ago KPS AG Announces Third Quarter Financial Results for 2023/2024 EBITDA Revenue Financial Forecast Quarterly Results Cost-cutting
Published on 03/24/2025 at 14:20, 3 hours 57 minutes ago MicroVision Announces Appointment of Industry Veteran as CTO
Published on 03/24/2025 at 14:00, 4 hours 17 minutes ago DEXIS to Showcase Cutting-Edge Innovations at IDS 2025
Published on 03/24/2025 at 13:00, 5 hours 17 minutes ago Tharimmune Announces Positive Results for Novel Oral Monoclonal Antibody TH023 Targeting Tumor Necrosis Factor-alpha
Published on 03/24/2025 at 12:30, 5 hours 47 minutes ago MIRA Pharmaceuticals Signs Binding Letter of Intent to Acquire SKNY Pharmaceuticals, Securing a $5 Million Capital Infusion to Advance Weight Loss and Smoking Cessation Drug Development
Published on 03/24/2025 at 12:30, 5 hours 47 minutes ago Stillwater Critical Minerals Welcomes Executive Order to Prioritize and Accelerate Domestic Mining and Mineral Production in the United States of America
Published on 03/24/2025 at 17:45, 32 minutes ago LIGHTON announces coverage initiation of its stock by Portzamparc –BNP Paribas Group.
Published on 03/24/2025 at 17:45, 32 minutes ago LIGHTON annonce l’initiation de couverture de son titre par Portzamparc – Groupe BNP Paribas.
Published on 03/24/2025 at 17:45, 32 minutes ago Newron proposes renowned biopharma company founder and entrepreneur Dr. Chris Martin for election as Independent Chairman
Published on 03/24/2025 at 17:10, 1 hour 6 minutes ago Stabilus SE: Invitation to the Capital Markets Day in Koblenz on June 4, 2025
Published on 03/24/2025 at 17:46, 31 minutes ago Reporting on share buyback transactions carried out between March 17 and March 21, 2025
Published on 03/24/2025 at 17:46, 31 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 17 au 21 mars 2025
Published on 03/24/2025 at 17:45, 32 minutes ago NFL Biosciences presents the immunological analysis results of its phase 2 CESTO II study confirming the efficacy of NFL-101, its first-in-class treatment for tobacco addiction
